Evaluating the risk of extraocular tumour spread following intravitreal injection therapy for retinoblastoma: A systematic review

British Journal of Ophthalmology

Volumn 97, Issue 10, 2013, Pages 1231-1236

  Smith, Stephen J ^a,c   Smith, Brian D ^b  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CLINDAMYCIN; DACTINOMYCIN; MELPHALAN; METHOTREXATE; RANIBIZUMAB; SITIMAGENE CERADENOVEC; THIOTEPA;

BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CRYOTHERAPY; EQUIPMENT CONTAMINATION; EXTRAOCULAR METASTASIS; FOLLOW UP; HUMAN; HYPERTHERMIC THERAPY; INJECTION; LOW LEVEL LASER THERAPY; METASTASIS; OPHTHALMIC NEEDLE; PATIENT SAFETY; PRIORITY JOURNAL; PROBABILITY; RETINOBLASTOMA; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SAFETY ENHANCING INJECTION TECHNIQUE; SYSTEMATIC REVIEW; TUMOR CELL; TUMOR SEEDING; VITREOUS DISEASE; VITREOUS REFLUX;

NEOPLASIA; RETINA; VITREOUS;

ANTINEOPLASTIC AGENTS; HUMANS; INTRAVITREAL INJECTIONS; NEOPLASM SEEDING; RETINAL NEOPLASMS; RETINOBLASTOMA; RISK FACTORS;

EID: 84884673027     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2013-303188     Document Type: Review

References (36)

1. Shields CL, Honavar SG, Shields JA, et al. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma. Arch Ophthalmol 2002;120:460-4.
2. Kim J, Do H, Egbert P. Enucleated eyes after failed intra-arterial infusion of chemotherapy for unilateral retinoblastoma: histopathologic evaluation of vitreous seeding. Clin Ophthalmol 2011;5:1655-8.
3. Suzuki S, Tamane T, Mohri M, et al. Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis. Ophthalmology 2011;118:2081-7.
4. Ericson LA, Rosengren BHO. Tests of intravitreous chemotherapy in retinoblastoma (in Transactions of the Swedish ophthalmological society 1958-1960). Acta Ophthalmol 1962;40:104-24.
5. Karcioglu Z, Gordon R, Karcioglu G. Tumor seeding in ocular fine needle aspiration biopsy. Ophthalmology 1985;92:1763-7.
6. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology, a proposal for reporting. JAMA 2000;283:2008-12.
7. Ericson LA, Rosengren BH. Present therapeutic resources in retinoblastoma. Acta Ophthalmol 1961;39:569-76.
8. Seregard S, Koch E, Trampe EA. Intravitreal chemotherapy for recurrent retinoblastoma in an only eye. Br J Ophthalmol 1995;79:194-5.
9. Lee V, Hungerford JL, Bunce C, et al. Globe conserving treatment of the only eye in bilateral retinoblastoma. Br J Ophthalmol 2003;87:1374-80.
10. Suzuki S, Kaneko A. Vitreous injection therapy of melphalan for retinoblastoma. XVth Biannual Meeting, International Society of Ocular Oncology, 14-17 November 2011, Buenos Aires, Argentina (Abstract).
11. Akiyama M, Yamaoka M, Terao YM, et al. Reduced cycles of systemic chemotherapy with following more focused local treatment for intraocular retinoblastoma. 44th Congress of the International Society of Paediatric Oncology (SIOP), 5-8 October 2012, London, UK (Abstract).
12. Munier FL, Soliman S, Moulin AP, et al. Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilization of the needle track. Br J Ophthalmol 2012;96:1084-87.
13. Wells JR, Hubbard GB III. The effect of intravitreal bevacizumab in the treatment of Coats disease in children. Retina 2011;31:427-8; author reply.
14. Seregard S, Singh AD. Retinoblastoma: direct chemotherapeutic drug delivery into the vitreous cavity. Br J Ophthalmol 2012;96:473-4.
15. Goble RR, McKenzie J, Kingston JE, et al. Orbital recurrence of retinoblastoma successfully treated by combined therapy. Br J Ophthalmol 1990;74:97-8.
16. Murthy R, Honavar SG, Vemuganti GK, et al. Systemic metastasis following hyphema drainage in an unsuspected retinoblastoma. J Pediatr Ophthalmol Strabismus 2007;44:120-3.
17. Kaneko A. Teach us about the current treatments of retinoblastoma. Atarashii Ganka 1996;13:229-33 (in Japanese).
18. Kaneko A. Japanese contributions to ocular oncology. Int J Clin Oncol 1999;4:321-6.
19. Kaneko A, Suzuki S. Eye-preservation treatment of retinoblastoma with vitreous seeding. Jpn J Clin Oncol 2003;33:601-7.
20. Suzuki S, Kaneko A. Management of intraocular retinoblastoma and ocular prognosis. In J Clin Oncol 2004;9:1-6.
21. Yamane T, Kaneko A, Mohri M. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. In J Clin Oncol 2004;9:69-73.
22. Matsubara H, Makimoto A, Higa T, et al. A multidisciplinary treatment strategy that includes high-dose chemotherapy for metastatic retinoblastoma without CNS involvement. Bone Marrow Transplant 2005;35:763-6.
23. Kaneko A. Treatment of vitreous seed of retinoblastoma recurrent after chemoreduction using vitreous injection of melphalan. World Congress of Ophthalmology, February 2006, Sao Paulo, Brazil (Abstract).
24. Ohshima K-I, Kaneko T, Takagi S, et al. Clinicopathological investigation of a retinoblastoma eye enucleated after vitreous surgery with melphalan perfusion. Jpn J Ophthalmol 2009;53:180-1.
25. Yanagisawa T, Fukuoka K, Suzuki T, et al. Japan retinoblastoma group study: novel local chemotherapies can reduce the burden of systemic chemotherapy to achieve eye preservation without EBRT. International Society of Ocular Oncology, 8-11 September 2009, Cambridge, UK (Abstract).
26. Kaneko A, Moori M, Takeuchi S. Our recent modifications of local chemotherapy for preservation of eyes with retinoblastoma. International Society of Ocular Oncology, 8-11 September 2009, Cambridge, UK (Abstract).
27. Araki Y, Matsuyama Y, Kobayashi Y, et al. Secondary neoplasms after retinoblastoma treatment: retrospective cohort study of 754 patients in Japan. Jpn J Clin Oncol 2011;41:373-9.
28. Ghassemi F, Ghadimi H, Amoli FA, et al. Diffuse infiltrating retinoblastoma coexisting with ocular toxoplasmosis. Int Ophthalmol Published Online First: 16 Mar 2013. doi:10.1007/s10792-013-9753-3
29. Sun YB, Hui P, Punyara K, et al. Intravitreal injection of melphalan in the treatment of retinoblastoma with vitreous cavity seeding. Chin Med J 2013;126:1587.
30. Boon CJF, Crama N, Klevering BJ, et al. Reflux after intravitreal injection of bevacizumab. Ophthalmology 2008;115:1271; author reply.
31. Smith SJ, Pulido JS, Salomao DR, et al. Combined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seeds. Br J Ophthalmol 2012;96:1073-7.
32. Ghassemi F, Shields CL. Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma. Arch Ophthalmol 2012;130:1268-71.
33. Chevez-Barrios P, Chintagumpala M, Mieler W, et al. Response of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovir. J Clin Oncol 2005;23:7927-35.
34. Kivela T, Eskelin S, Paloheimo M. Intravitreal methotrexate for retinoblastoma. Ophthalmology 2011;118:1689 e1-6.
35. Brodie SE, Munier FL, Francis JH, et al. Persistence of retinal function after intravitreal melphalan injection for retinoblastoma. Doc Ophthalmol 2013;126:79-84.
36. Abramson DH, Dunkel IJ, Brodie SE, et al. A phase 1/11 study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma: initial results. Ophthalmology 2008;115:1398-1404.e1.